ENGNW icon

enGene Holdings Warrants

2.48 USD
--0.18
6.77%
At close Updated Oct 17, 4:00 PM EDT
1 day
-6.77%
5 days
125.45%
1 month
230.67%
3 months
185.06%
6 months
235.14%
Year to date
175.56%
1 year
22.77%
5 years
148%
10 years
148%
 

About: enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Employees: 57

0
Funds holding %
of 7,496 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™